4D Spatial Intelligence
for Drug Discovery
VoxelTox fuses World Models with LLMs to predict molecular binding dynamics in full 4D — replacing months of simulation with seconds of deterministic inference.
4D
Spatial-Temporal
10⁴×
Faster than MD
$70B
Market (2030)
The Opportunity
Current drug discovery AI cannot model
what actually happens inside the body.
Industry Status Quo
Static & Probabilistic
Molecular Dynamics
Days to weeks of compute for microsecond-scale simulation. Cannot scale to virtual screening.
AlphaFold & Variants
Single static conformation. Blind to binding dynamics, induced fit, and temporal conformational shifts.
Data Silos
1D sequences, 2D microscopy, 3D structures handled by separate tools — losing cross-dimensional signal.
VoxelTox Approach
Dynamic & Deterministic
4D Occupancy Forecasting
Predicts how molecular binding evolves over time — learned from data, not brute-forced from equations.
World Model + LLM Fusion
LLM reasons about chemistry; World Model simulates physics. Bidirectional correction eliminates false positives.
Native Multi-Modal (1D/2D/3D/4D)
Cross-attention fusion of sequences, Cryo-EM, voxels, and dynamics — like sensor fusion in autonomous driving.
Architecture
Multi-dimensional sensor fusion,
applied to molecular space.
Analogous to how autonomous vehicles fuse LiDAR, cameras, and radar — VoxelTox fuses four dimensions of biological data into a unified spatial understanding.
Input Modalities
1D — Sequences & Literature
LLM Semantic Encoding
2D — Cryo-EM Microscopy
Vision Transformer
3D — Protein Structures
Spatial Voxelization
4D — Temporal Dynamics
World Model Forecasting
Core Engine
Shared Latent Space
Cross-attention alignment across all four dimensions
Output
Validated Lead Compound
Pre-validated against 4D spatial-temporal constraints
Business Model
Platform to Pipeline
A phased approach from technology validation to value capture across the drug discovery stack.
Phase 1 · Year 1–2
Compute SaaS Platform
High-precision 4D virtual screening as a service for pharma R&D teams. Validate the technology with paying customers.
Phase 2 · Year 2–4
Joint Pipeline Development
Co-develop lead compounds with wet-lab partners. Shared IP and milestone-based revenue from co-development agreements.
Phase 3 · Year 4+
Platform Licensing
License VoxelTox as the industry-standard spatial prediction engine across global pharma R&D organizations.
Fundraising
Seeking Strategic Partners
Seed round of $3M–$5M targeting compute infrastructure, cloud ecosystem access, and strategic capital from partners aligned with our mission.
Compute Infrastructure
GPU clusters for training and high-throughput inference at scale.
Pharma Collaborations
Joint development with drug discovery organizations for pipeline validation.
Wet Lab Partners
Experimental validation to close the loop between prediction and confirmation.